Profound Medical (PRN) Set to Announce Quarterly Earnings on Thursday

Profound Medical (TSE:PRN) is scheduled to issue its quarterly earnings data after the market closes on Thursday, November 7th. Analysts expect the company to announce earnings of C($0.42) per share for the quarter.

Profound Medical (TSE:PRN) last issued its quarterly earnings data on Thursday, August 8th. The company reported C($0.38) EPS for the quarter, hitting the consensus estimate of C($0.38). The business had revenue of C$3.06 million for the quarter, compared to analyst estimates of C$3.42 million.

Profound Medical Stock Performance

Shares of Profound Medical stock opened at C$10.39 on Thursday. The company has a market capitalization of C$254.35 million, a PE ratio of -6.26 and a beta of 0.81. Profound Medical has a 12 month low of C$9.55 and a 12 month high of C$16.00. The company has a current ratio of 8.61, a quick ratio of 14.98 and a debt-to-equity ratio of 16.95. The stock’s fifty day simple moving average is C$11.01 and its 200 day simple moving average is C$11.53.

Insider Buying and Selling

In other Profound Medical news, Senior Officer Rashed Osman Dewan acquired 9,765 shares of the company’s stock in a transaction that occurred on Thursday, August 15th. The shares were acquired at an average price of C$12.85 per share, with a total value of C$125,480.25. 8.62% of the stock is currently owned by company insiders.

Profound Medical Company Profile

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.